CONCLUSION
To conclude, high index of suspicion for mycobacterial infection is
required for immunocompromised patients with prolonged fever or unusual
presentation. Mycobacterial osteomyelitis is rare, difficult to diagnose
and treat, and may necessitate prolonged interruption of anti-leukemic
therapy. Multidisciplinary collaboration in patient management is
crucial. Toxicity due to long-term use of antimicrobials should not be
overlooked.